Pathstone Family Office, LLC Novartis Ag Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Novartis Ag stock. As of the latest transaction made, Pathstone Family Office, LLC holds 26,255 shares of NVS stock, worth $2.73 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

26,255

Previous 18,661 40.69%

Holding current value

$2.73 Million

Previous $1.88 Million 42.01%

% of portfolio

0.02%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $719,379 - $798,357	7,594 Added 40.69%	26,255 $2.67 Million
Q2 2023 Jan 12, 2024	SELL	$92.52 - $104.91 $702,596 - $796,686	-7,594 Reduced 28.92%	18,661 $1.88 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $79,659 - $90,327	-861 Reduced 4.41%	18,661 $1.88 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $496,346 - $575,607	-6,202 Reduced 24.11%	19,522 $1.8 Million
Q4 2022 Oct 23, 2023	BUY	$75.55 - $92.52 $291,547 - $357,034	3,859 Added 17.65%	25,724 $2.33 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $71,772 - $87,894	950 Added 3.83%	25,724 $2.33 Million
Q3 2022 Oct 23, 2023	BUY	$74.61 - $87.26 $384,241 - $449,389	5,150 Added 30.81%	21,865 $1.66 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $186,525 - $218,150	2,500 Added 11.22%	24,774 $1.89 Million
Q2 2022 Oct 23, 2023	SELL	$80.52 - $93.75 $156,691 - $182,437	-1,946 Reduced 10.43%	16,715 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $755,438 - $879,562	9,382 Added 72.77%	22,274 $1.88 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $78,107 - $88,354	975 Added 8.18%	12,892 $1.14 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $16,418 - $18,154	-206 Reduced 1.7%	11,917 $1.04 Million
Q3 2021 Nov 16, 2021	BUY	$81.78 - $95.14 $146,467 - $170,395	1,791 Added 17.33%	12,123 $992,000
Q2 2021 Aug 31, 2021	BUY	$85.24 - $94.15 $276,262 - $305,140	3,241 Added 45.71%	10,332 $943,000
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $527,970 - $622,625	6,323 Added 823.31%	7,091 $606,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $1,014 - $1,227	13 Added 1.72%	768 $73,000
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $61,102 - $68,780	755 New	755 $66,000
Q1 2020 Jun 11, 2020	BUY	$70.67 - $99.01 $53,355 - $74,752	755 New	755 $62,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $74,274 - $104,059	-1,051 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $24,967 - $28,229	296 Added 39.21%	1,051 $996,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $15,909 - $19,580	-211 Reduced 21.84%	755 $69,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $15,892 - $18,177	211 Added 27.95%	966 $93,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $55,613 - $61,925	755 New	755 $65,000
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $7,010 - $7,922	-108 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $7,602 - $9,088	108 New	108 $9,000
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $51,898 - $54,089	-700 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	700	700 $59,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Novartis Ag Transaction History